<?xml version="1.0" encoding="UTF-8"?><own:edgarSubmission xmlns:com="http://www.sec.gov/edgar/common" xmlns:own="http://www.sec.gov/edgar/ownership">
  <!-- Generated by Workiva -->
  <own:headerData>
    <own:submissionType>144</own:submissionType>
    <own:filerInfo>
      <own:filer>
        <own:filerCredentials>
          <own:cik>0001518611</own:cik>
          <own:ccc>XXXXXXXX</own:ccc>
        </own:filerCredentials>
      </own:filer>
      <own:liveTestFlag>LIVE</own:liveTestFlag>



    </own:filerInfo>
  </own:headerData>
  <own:formData>
    <own:issuerInfo>
      <own:issuerCik>0001157601</own:issuerCik>
      <own:issuerName>Madrigal Pharmaceuticals, Inc.</own:issuerName>
      <own:secFileNumber>001-33277</own:secFileNumber>
      <own:issuerAddress>
        <com:street1>1001 Conshohocken State Road</com:street1>
        <com:street2>Suite 2-350</com:street2>
        <com:city>West Conshohocken</com:city>
        <com:stateOrCountry>PA</com:stateOrCountry>
        <com:zipCode>19428</com:zipCode>
      </own:issuerAddress>
      <own:issuerContactPhone>267-824-2827</own:issuerContactPhone>
      <own:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>William John Sibold</own:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <own:relationshipsToIssuer>
        <own:relationshipToIssuer>Officer and Director</own:relationshipToIssuer>
      </own:relationshipsToIssuer>
    </own:issuerInfo>
    <own:securitiesInformation>
      <own:securitiesClassTitle>Common Stock</own:securitiesClassTitle>
      <own:brokerOrMarketmakerDetails>
        <own:name>Morgan Stanley Smith Barney LLC Executive Financial Services</own:name>
        <own:address>
          <com:street1>1 New York Plaza, 8th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10004</com:zipCode>
        </own:address>
      </own:brokerOrMarketmakerDetails>
      <own:noOfUnitsSold>6362</own:noOfUnitsSold>
      <own:aggregateMarketValue>3398325.92</own:aggregateMarketValue>
      <own:noOfUnitsOutstanding>23104126</own:noOfUnitsOutstanding>
      <own:approxSaleDate>09/09/2026</own:approxSaleDate>
      <own:securitiesExchangeName>Nasdaq Stock Market</own:securitiesExchangeName>
    </own:securitiesInformation>
    <own:securitiesToBeSold>
      <own:securitiesClassTitle>Common Stock</own:securitiesClassTitle>
      <own:acquiredDate>09/08/2026</own:acquiredDate>
      <own:natureOfAcquisitionTransaction>Restricted Stock Unit Grant</own:natureOfAcquisitionTransaction>
      <own:nameOfPersonfromWhomAcquired>Issuer</own:nameOfPersonfromWhomAcquired>
      <own:isGiftTransaction>N</own:isGiftTransaction>
      <own:amountOfSecuritiesAcquired>6362</own:amountOfSecuritiesAcquired>
      <own:paymentDate>09/08/2026</own:paymentDate>
      <own:natureOfPayment>Vesting of Restricted Stock Units</own:natureOfPayment>
    </own:securitiesToBeSold>
    <own:nothingToReportFlagOnSecuritiesSoldInPast3Months>N</own:nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <own:securitiesSoldInPast3Months>
      <own:sellerDetails>
        <own:name>William John Sibold</own:name>
        <own:address>
          <com:street1>c/o Madrigal Pharmaceuticals, Inc.</com:street1>
          <com:street2>1001 Conshohocken State Road Suite 2-350</com:street2>
          <com:city>West Conshohocken</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19428</com:zipCode>
        </own:address>
      </own:sellerDetails>
      <own:securitiesClassTitle>common stock</own:securitiesClassTitle>
      <own:saleDate>07/20/2026</own:saleDate>
      <own:amountOfSecuritiesSold>2500</own:amountOfSecuritiesSold>
      <own:grossProceeds>1368250</own:grossProceeds>
    </own:securitiesSoldInPast3Months>
    <own:remarks>The sale reported herein represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover certain tax withholding obligations in connection with the vesting of Restricted Stock Units previously granted to the Reporting Person. This sale was automatic and not at the discretion of the Reporting Person.</own:remarks>
    <own:noticeSignature>
      <own:noticeDate>09/09/2026</own:noticeDate>
      <own:signature>/s/ William Sibold</own:signature>
    </own:noticeSignature>
  </own:formData>
</own:edgarSubmission>
